Literature DB >> 253573

Comparative evaluation of piperacillin in vitro.

G M Dickinson, T J Cleary, T A Hoffman.   

Abstract

The minimal inhibitory concentrations of piperacillin and seven other betalactam antibiotics were determined against 407 bacterial isolates. Piperacillin was found to be more active than ampicillin against susceptible gram-negative bacilli and more active than either carbenicillin or ticarcillin against Pseudomonas aeruginosa and streptococci. Although piperacillin was active against Klebsiella pneumoniae, this activity was less than that of the cephalosporins. Piperacillin was not active against penicillin-resistant Staphylococcus aureus and Enterobacteriaceae that were resistant to the other test antibiotics.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 253573      PMCID: PMC352580          DOI: 10.1128/AAC.14.6.919

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Inhibition of Swarming of Proteus by Sodium Tetradecyl Sulfate, beta-Phenethyl Alcohol, and p-Nitrophenylglycerine.

Authors:  R Kopp; J Müller; R Lemme
Journal:  Appl Microbiol       Date:  1966-11

2.  In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

Authors:  K Ueo; Y Fukuoka; T Hayashi; T Yasuda; H Taki; M Tai; Y Watanabe; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

4.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

5.  Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.

Authors:  W L George; R P Lewis; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.

Authors:  R N Jones; C Thornsberry; A L Barry; P C Fuchs; T L Gavan; E H Gerlach
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

7.  In vitro studies of piperacilin, a new semisynthetic penicillin.

Authors:  D J Winston; D Wang; L S Young; W J Martin; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

  7 in total
  14 in total

1.  Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections.

Authors:  R V McCloskey
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

2.  Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

3.  In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.

Authors:  L Pulliam; W K Hadley; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

4.  Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.

Authors:  M A Bertram; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

5.  Piperacillin in early neonatal infection.

Authors:  M Placzek; A Whitelaw; S Want; M Sahathevan; J Darrell
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

6.  The effect of piperacillin prophylaxis on the colonic microflora In patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; C E Nord; S Sjöstedt
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

7.  Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.

Authors:  R G Robinson; J Saunders; R Cassel; C S Block; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.

Authors:  G L Simon; D R Snydman; F P Tally; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

Review 9.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

10.  Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.

Authors:  H Saito; K Sato; B W Jin
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.